Today: 17 May 2026
Salesforce stock price today: CRM edges up after-hours as buyback details land in new filing
4 March 2026
2 mins read

Salesforce stock price today: CRM edges up after-hours as buyback details land in new filing

New York, March 3, 2026, 17:40 ET — Trading after the bell.

  • Salesforce shares climbed roughly 1.6% after hours, bucking the broader U.S. market’s decline earlier in the day.
  • The company’s latest annual filing detailed its $50 billion share repurchase authorization, along with the recent rate of buybacks.
  • Investors are trying to gauge if buybacks might help stabilize software stocks, with AI-driven uncertainty still hanging over the sector.

Salesforce (CRM.N) climbed roughly 1.6% to $196.05 in after-hours trade Tuesday, following a session range between $187.22 and $198.57. Still, shares sit far from the 52-week high.

This was notable with the rest of the tape choppy. Investors were still picking through the aftermath of a sharp risk-off session—blame inflation jitters and climbing energy prices—but software stocks managed to outperform much of the group.

So Salesforce is right back where it often lands—a high-profile, easily traded software giant standing in for the broader fate of “old” SaaS as AI forces a rethink on spending and product timelines. Buybacks figure into the story these days too, for better or worse.

U.S. stocks slipped on Tuesday, pressured by renewed fears over the Middle East conflict and rising energy prices fueling inflation worries. Still, indexes clawed back from earlier lows. “Investors are growing anxious about the duration of the war,” said Joseph Tanious of Northern Trust Asset Management. Reuters

Salesforce’s latest annual report to the U.S. Securities and Exchange Commission shows that back in February, the board cleared a fresh $50.0 billion buyback plan, taking the place of what was left under the old authorization. For the fiscal year that wrapped up on Jan. 31, 2026, the company put $12.6 billion toward share repurchases. The filing also lists a $0.44 per share quarterly dividend payable April 23 to anyone on record as of April 9.

The filing comes as investors argue over whether buybacks are really enough to stem losses in software stocks. The S&P 500 software index has dropped 28% since late October, according to Reuters, and U.S.-listed software companies have greenlit $70.5 billion in stock repurchases since Jan. 12. “When a company announces a buyback … that is an attempt to stop the decline,” said Andrew Slimmon at Morgan Stanley Investment Management. Peter Tuz at Chase Investment Counsel put it more bluntly: “I don’t think the buybacks are enough.” Reuters

Buybacks boost earnings per share, just by reducing the number of shares out there. But that’s not a solution for demand, and investors still want evidence AI won’t eat into subscription prices or speed up churn.

Salesforce, meanwhile, is betting big on “agentic” AI—software built to act, not just respond to prompts—and it’s doubling down on this push through its partner network.

Salesforce on Monday announced a shakeup to its consulting partner program, trimming it down to just two tiers and shifting its partner recognition framework to focus on 28 core competencies linked directly to customer results. “Specialization is the new currency of the agentic era,” wrote Salesforce executive Nick Johnston in a company post. Salesforce

Competitive pressure isn’t theoretical. Larger rivals are also deploying buybacks and touting their AI credentials. For smaller software names, pitching a durable growth narrative has become much harder amid a choppy tape.

The risk cuts both ways. Rising energy costs could still drive yields higher, squeezing software valuations further—buybacks won’t be enough to counter that. And if AI convinces customers that swapping out software bundles is less of a hassle, investors will want to see it in bookings and renewals, not just another round of capital-return headlines.

Now, attention shifts to Salesforce and any sign of accelerated buybacks following the fresh authorization. More immediately, eyes are on the cash-return timeline: April 9 stands as the record date for the upcoming dividend, scheduled for April 23 payout.

Stock Market Today

  • S&P Global Stock Approaches Key Support Level with Strong Fundamentals
    May 16, 2026, 10:34 PM EDT. S&P Global (SPGI) shares are trading within a historically significant support zone of $383 to $423, a range that has triggered multiple rebounds averaging 18% gains. The firm surpassed Q1 2026 revenue and earnings estimates, saw 10% and 14% growth respectively, and maintains robust margins with a 40.9% operating margin and 35.3% free cash flow margin. Analysts currently rate SPGI as a 'Strong Buy' with price targets 25-37% above current levels. Despite minor revisions due to foreign exchange impacts, organic growth remains solid at 6-8%. The stock trades at a 25.1 P/E ratio, slightly above the financial sector median but below its historical levels, indicating potential undervaluation amid credit and structural market pressures. Nonetheless, past market shocks caution investors on inherent volatility risks.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Occidental Petroleum stock price whipsaws as oil jumps on Iran conflict; OXY traders eye March 4 deadline
Previous Story

Occidental Petroleum stock price whipsaws as oil jumps on Iran conflict; OXY traders eye March 4 deadline

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 04.03.2026

Go toTop